Coronavirus (COVID-19) Update: FDA Authorizes First Test
for Patient At-Home Sample Collection
Last week the FDA authorized the first diagnostic test with a home collection option for COVID-19. This reissued EUA for LabCorp’s molecular test permits testing of a sample collected from the patient’s nose using a designated self-collection kit that contains nasal swabs and saline. Once patients self-swab to collect their nasal sample, they mail their sample, in an insulated package, to a LabCorp lab for testing. LabCorp intends to make the Pixel by LabCorp COVID-19 Test home collection kits available to consumers in most states, with a doctor’s order, in the coming weeks.